Introduction
============

In children, hypertension is a rare disease with a prevalence of less than 1%[@B1]. Despite this, it is still very important because hypertension in children is highly likely to have a serious underlying illness compared to adult patients[@B2].

Hypertension can cause various complications, with hypertensive encephalopathy a particularly unfavorable prognosis. Hypertensive encephalopathy is a common manifestation of malignant hypertension which is characterized by grade III/IV retinopathy and widespread endothelial damage with uncontrolled hypertension[@B3]. It could be one of the first symptoms of secondary hypertension in pediatric patients compared to adults. Such malignant hypertension is more commonly associated with renal hypertension in pediatric patients because of the activation of the renin angiotensin system and increased activity of sympathetic tone[@B4].

Hypertensive encephalopathy is defined as acute brain dysfunction such as severe headache, changes in consciousness, seizure, and retinal hemorrhage induced by sustained severe hypertension[@B5]. The etiologies of hypertensive encephalopathy are well identified, but the exact pathophysiology of hypertensive encephalopathy has not been established. However, it can be explained in 2 concepts. First, according to autoregulation breakthrough conception, cerebral arterioles are forced to dilate, leading to vasogenic edema[@B6]. Second, in overregulation conception, brain vessel spasm in response to acute hypertension results in cerebral ischemia and cytotoxic edema[@B7]. Overregulation conception is thought to be related to the release of humoral vasoconstrictors that are normally increased when hypertension occurs. The latter concept is explained as the cause of the most characteristic posterior reversible encephalopathy syndrome (PRES) lesion. In hypertensive encephalopathy, brain edema can cause stimulation of stretch receptors in the fourth ventricle, which can make the hypertension worse[@B8]. These theories suggest that hypertensive encephalopathy can have different characteristics depending on the underlying diseases, because each etiology has a different contributing factor for hypertension.

For this reason, we tried to assess the relationship between the underlying causes of hypertensive encephalopathy and clinical characteristics or brain MRI findings in pediatric patients.

Materials and methods
=====================

1. Patients
-----------

The total number of pediatric patients (younger than 20 years of age) who were admitted to our Pediatric Department with hypertension as the main symptom between 2000 and 2015 was 197.

Hypertension was diagnosed when the systolic or diastolic blood pressure was over the 95% percentile for the relevant age categories. All initial blood pressure was measured from an upper extremity with an appropriate pediatric manual arm cuff. Blood pressure was measured continuously when neurologic symptoms were present at the time of admission.

Hypertensive encephalopathy was diagnosed when patient showed hypertension with more than one neurologic symptom including headache, seizure, dysarthria, motor weakness, or loss of consciousness[@B5].

Patients underwent brain MRI and electroencephalography (EEG) within one day of hospitalization. Patients with PRES lesion on brain MRI and those with other findings including infarction or hemorrhage without PRES lesion on brain MRI were classified into 'typical MRI' group and 'atypical MRI' group, respectively.

We reviewed 33 patients who showed hypertensive encephalopathy. Among them, 16 patients were additionally excluded because of incomplete data (4 patients), or lack of brain imaging study (8 patients), or neurologic symptoms which already had occurred before hypertension onset (4 patients). Consequently, we enrolled 17 children with hypertensive encephalopathy.

Patients were divided into 2 groups according to their cause, and the clinical characteristics of each group were analyzed. The renal group included renal artery stenosis (4), acute poststreptococcal glomerulonephritis (2), lupus nephritis (2), and acute kidney injury (1). The nonrenal group included essential hypertension (4), pheochromocytoma (2), thyrotoxicosis (1), and acute promyelocytic leukemia (1). Blood pressure, clinical manifestations and prognosis, EEG, and brain MRI findings were compared between the groups.

This study was performed with approval from the Institutional Review Board of Chonbuk National University Research Council.

2. Statistical analysis
-----------------------

Statistical analysis was conducted with IBM SPSS ver. 18.0 (IBM Co., Armonk, NY, USA). A Pearson chi-square test was used to compare symptoms and radiologic findings between the groups. For comparing blood pressure and prevalence, a simple correlation analysis and Mann-Whitney *U* test were used. *P*\<0.05 was considered to be statistically significant.

Results
=======

1. Clinical characteristics
---------------------------

Nine out of 17 patients were included in the renal origin hypertension group and 8 patients were in the nonrenal origin hypertension group ([Table 1](#T1){ref-type="table"}). All patients were newly diagnosed with hypertensive encephalopathy and no patients had been diagnosed with underlying disease related to hypertension. Mean age of onset was not significantly different between groups (renal group: nonrenal group=11.7:13.0 years old; male:female=8:9; [Table 1](#T1){ref-type="table"}). In the renal group, mean systolic and diastolic blood pressure was 172.5±36.9 mmHg and 108.7±18.8 mmHg, respectively. Mean systolic blood pressure of nonrenal group was 137.1±11.1 mmHg and the mean diastolic pressure was 87.1±17.0 mmHg. These results had a statistically significant difference (*P*\<0.05).

Eleven out of seventeen patients manifested seizure, which was the most common symptom in our study group (64.7%). Seizure was more common in the renal group, and there was a significant difference when compared to the occurrence of seizure in the nonrenal group (88.9% vs. 37.5%, *P*\<0.05). Seven patients showed seizure before admission, and 4 patients had seizure after admission. Patients who manifested seizure after admission were measured to have symptoms at an average of 180±48.8 minutes after admission. Among them, only 1 patient had progressed to status epilepticus. Nine out of 11 patients showed generalized tonic clonic seizure; the other 2 patients had tonic seizure. Additionally, other clinical presentations included headache, blurred vision, palpitation, and dysarthria ([Table 2](#T2){ref-type="table"}). Eight patients manifested headache, and half of them had both headache and seizure. Blurred vision (2 patients), palpitation (2 patients), and dysarthria (1 patient) were also seen, but these symptoms usually occurred together rather than as solitary symptoms. The detailed individual results of the patients are shown in [Table 3](#T3){ref-type="table"}.

2. Brain MRI and EEG
--------------------

Brain MRI was performed in all 17 patients, of whom 7 patients had typical PRES lesion (41.2%), and 2 had multifocal infarction without PRES lesion (11.8%). In the renal group, with all patients manifesting seizures, every patient showed abnormal MRI findings (100%), and 6 patients had PRES lesion (66.6%). All patients with PRES lesions showed seizures, but PRES lesions were improved after treatment ([Fig. 1](#F1){ref-type="fig"}). On the other hand, 3 out of 8 patients showed abnormal MRI findings (37.5%), and only 1 patient (12.5%) showed a PRES lesion in the nonrenal group (*P*\<0.05). Magnetic resonance angiography (MRA) was done only in 5 patients, but there were no significant findings suggesting cerebral vasoconstriction. EEG was performed in 11 patients. EEG results for 8 patients corresponded with MRI findings (72.7%). However, 3 patients had abnormalities only in EEG findings and they had a normal MRI pattern. These patients all belonged to the nonrenal group, as described in [Fig. 2](#F2){ref-type="fig"}.

3. Outcome and prognosis
------------------------

Clinical outcomes were not as detrimental as already known[@B7]. One patient who was diagnosed with lupus nephritis in renal group died (5.8%) and another patient in nonrenal group had dysarthria (5.8%), but the other patients in both groups completely recovered after antiepileptic and hypertensive treatment. Antihypertensive therapy initiated by bolus, and continuous intravenous drug use such as calcium channel blocker (1--5 µg/kg/min) and beta blocker (0.25--3 mg/kg/hr). After acute phase treatment was done, 4 patients in renal group required angiotensin converting enzyme inhibitor (23.5%) for blood pressure control, but other patients in nonrenal group did not take a medicine.

Discussion
==========

Hypertension in children is usually related to secondary hypertension, unlike in adults in which primary hypertension is the major cause of hypertension[@B7]. Malignant hypertension could lead to end-organ damage, but only 1% of hypertension patients undergo a hypertensive crisis[@B5][@B9]. However, if hypertensive crisis occurs among untreated patients, then the mortality rate is approximately 79%[@B10]. Therefore, early detection and evaluation for hypertension is very important for decreasing the mortality rate, and at the same time, attempts to resolve an underlying disease should be made. However, the study of pediatric hypertension, especially malignant hypertension, has been limited owing to a low prevalence and difficulty in obtaining data.

Hypertensive encephalopathy can manifest seizures, intracranial hemorrhage, posterior reversible encephalopathy syndrome, and papilledema. In a narrow spectrum, hypertensive encephalopathy has the same meaning as posterior reversible encephalopathy syndrome, but any symptoms related to hypertension with neurologic impairment have been described as hypertensive encephalopathy in other studies[@B9]. In adult studies, headaches are the most common symptom, but other studies in the literature describe seizure as a common symptom in hypertensive encephalopathy[@B11][@B12]. In our study, seizure was the most common symptom and this finding was more prominent in the renal origin hypertension group than in the other group (*P*\<0.05). As seizure is an advanced manifestation of malignant hypertension compared to other neurologic symptoms, this result could mean that the renal origin hypertension group had more severe hypertension than the nonrenal origin group in this study.

Many of the young patients with secondary hypertension had renal disease; hence, evaluation of hypertension in children includes the use of renal ultrasonography, echocardiogram, and laboratory findings[@B13][@B14]. However, a direct correlation between hypertensive encephalopathy and renal disease has not been proven. Unlike other etiologies, hypertension originating from renal disease could cause severe hypertension by complex mechanisms, such as renin angiotensin system activation, fluid overload, activated sympathetic tone, and an electrolyte imbalance[@B15],[@B16]. This study showed that the renal origin hypertension group had higher mean blood pressure than the nonrenal origin hypertension. Similarly, seizure and PRES pattern MRI scans were easily observed in the renal group, and this is suggestive that typical hypertensive encephalopathy is more common in the renal group than in the nonrenal group.

The differences in the prevalence of typical findings between the groups were related to 2 major factors. First, higher blood pressure can make hypertensive encephalopathy more likely, and these can give rise to typical radiologic findings. Among our study groups, most of the patients with renal disease did not know they had hypertension before a hypertensive crisis attack. Hypertensive encephalopathy was the first symptom of their disease, so their peak and mean blood pressure could be higher than those in the other group because of untreated hypertension. As mentioned in previous studies, acute onset and high blood pressure were directly related with hypertensive encephalopathy onset; therefore, a difference between the 2 groups existed in this study. The other factor is related to a hypertensive encephalopathy mechanism. In the past, auto-regulatory vasoconstriction in the cerebral vasculature was thought to be the main cause of hypertensive encephalopathy[@B17][@B18]. However, in a recent study, vasodilatation according to acute increases in cerebral blood pressure was presented as a more persuasive idea[@B19]. Vasodilatation was mediated by prostaglandin synthesis, but sympathetic innervation was used to protect the affected organ. Therefore, a posterior lesion could be the most prevalent lesion in hypertensive encephalopathy because of less sympathetic innervation than the carotid circulation[@B20]. The cerebellum, brain stem, parietooccipital junction, basal ganglia, and frontal lobes are usually not affected by hypertensive encephalopathy owing to the same reasons, and pediatric patients could be more vulnerable than adults because of immature autoregulation[@B21]. As for the second factor, hypertension in renal disease is induced not only by activation of the sympathetic tone, but also by volume overloading, and hypertensive encephalopathy could occur easily.

Brain MRI is the most effective diagnostic tool in patients with hypertensive encephalopathy[@B22]. Cerebral edema induces dark abnormal signals in T1-weight images and bright abnormal signals in T2-weighted images. In our study, typical MRI findings showed the same results as in previous studies, but some patients presented with abnormal findings only on EEG and not MRI. As EEG has a specificity of 78%--98%, it could be more sensitive than radiologic images to detect early phase abnormalities, which did not appear on other images[@B23]. In recent studies, reversible cerebral vasoconstriction syndrome (RCVS) should be considered to newly diagnosed PRES patients[@B24]. Considering patient\'s age and symptoms, there is a little possibility to being diagnosed with RCVS in this study group. But to confirm diagnosis, MRA need to be considered in patients who showed atypical and normal MRI findings.

As the mean blood pressure was higher in the renal group, neurologic symptoms and typical MRI findings were also prominent in this group. However, all patients were included in the study based on peak blood pressure, and those who had no neurologic impairment despite high blood pressure were excluded. This finding could be meaningful in itself. This is a limited study because only 17 patients were suitable according to our criteria. Therefore, we cannot generalize the relationship between hypertensive encephalopathy and underlying diseases. For this, a wider range study with adult patients should be performed. Furthermore, other objective parameters, such as serologic biomarkers, could reveal the exact pathophysiology that could explain the corelation between underlying diseases and the initiation of hypertensive encephalopathy.

In conclusion, there are many underlying diseases that induce neurologic impairment. Therefore, when physicians suspect hypertensive encephalopathy, a differential diagnosis is important for proper treatment. The basic treatment for hypertensive encephalopathy is an antihypertensive drug; however, additional treatment for underlying diseases should be administered. Hence, we studied the characteristics of hypertensive encephalopathy in children who had different causes for hypertension compared to adults. In this study, renal disease was found to be a common cause of typical hypertensive encephalopathy. Therefore, it is critical that physicians should be aware of hypertensive encephalopathy and hypertensive crisis in children with renal origin hypertension.
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![(A) T2-weighted image of renal-origin hypertensive encephalopathy showing the parieto-occipital lesion, which demonstrates the typical magnetic resonance imaging findings of posterior reversible encephalopathy syndrome (arrow). (B) The 6-month follow-up image showing a full recovery state.](kjped-60-266-g001){#F1}

![Nontypical T2-weighted image of renal origin hypertensive encephalopathy, showing high signal intensity on the basal ganglia and left occipital area.](kjped-60-266-g002){#F2}

###### Characteristics of the patients according to underlying disease

![](kjped-60-266-i001)

  Characteristic               Renal-origin hypertension group (n=9)   Non--renal-origin hypertension group (n=8)
  ---------------------------- --------------------------------------- --------------------------------------------
  Sex, male:female             5:4                                     4:4
  Age (yr)                                                             
   Mean±SD                     11.7±4.3                                13.0±4.5
   Range                       8--20                                   4--16
  Mean blood pressure (mmHg)                                           
   Systolic                    172.5±36.9                              137.1±11.1
   Diastolic                   108.7±18.8                              87.1±17.0
  MRI findings                                                         
   Typical                     6 (66.7)                                1 (12.5)
   Atypical                    3 (33.4)                                2 (25.0)
   Normal                      0 (0)                                   5 (62.5)

Values are presented as mean±standard deviation (SD) or number (%) unless otherwise indicated.

MRI, magnetic resonance imaging.

###### Clinical manifestations of the patients with hypertensive encephalopathy

![](kjped-60-266-i002)

  Variable         Renal-origin hypertension group (n=9)   Non--renal-origin hypertension group (n=8)
  ---------------- --------------------------------------- --------------------------------------------
  Seizure          8 (88.9)                                3 (37.5)
  Headache         3 (33.3)                                5 (62.5)
  Blurred vision   1 (11.1)                                1 (12.5)
  Palpitation      0 (0)                                   2 (25)
  Dysarthria       0 (0)                                   1 (12.5)

###### Systemic review of the cases of hypertensive encephalopathy
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  Case   Age (yr)/sex   Diagnosis               Height (percentile)   BP (mmHg)   MRI         EEG
  ------ -------------- ----------------------- --------------------- ----------- ----------- --------------
  1      4/F            Thyrotoxicosis          103 cm (50--75)       130/70      Normal      S; Rt. Po
  2      20/M           Renal artery stenosis   180 cm (50--75)       160/120     Rt. P, O    
  3      13/F           Essentialhypertension   160 cm (50--75)       130/90      Rt. T       S, Sp; Rt. T
  4      9/M            Essentialhypertension   127 cm (10--25)       120/60      Rt. P       S; Lt. Po
  5      8/M            APSGN                   133 cm (75--90)       130/90      Both O      
  6      9/M            Renal artery stenosis   130 cm (25--50)       190/130     Both O      
  7      8/M            Renal artery stenosis   127 cm (25--50)       170/100     Both O      S; both Po
  8      12/M           Lupus nephritis         141 cm (10--25)       240/140     F, P, T     S; both Po
  9      17/F           Renal artery stenosis   168 cm (75--90)       200/100     Both B, P   S; F, P
  10     8/F            APSGN                   128 cm (50--75)       130/90      Rt. O       
  11     15/M           Pheochromocytoma        178 cm (75--90)       150/90      Normal      N
  12     14/M           Essentialhypertension   165 cm (50--75)       140/90      Normal      N
  13     11/M           ARF                     154 cm (90--95)       160/100     Both P, O   S; Rt.
  14     16/M           Pheochromocytoma        182 cm (75--90)       150/100     Normal      S; Lt.
  15     18/F           Essentialhypertension   161 cm (25--50)       140/110     Normal      
  16     12/F           Lupus nephritis         154 cm (50--75)       160/100     Rt. P, T    
  17     15/F           APL                     159 cm (25--50)       150/80      Both B, O   

BP, blood pressure; MRI, magnetic resonance imaging; EEG, electroencephalography; Rt, right; Lt, left; N, normal; F, frontal; P, parietal lobe; O, occipital; T, temporal; B, basal ganglia; S, slow wave; Sp, spike wave; Po, posterior; APL, acute promyelocytic leukemia; ARF, acute renal failure.
